These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 33146575)

  • 21. High-throughput LC-MS/MS assay for 6-methoxy-2-naphthylacetic acid, an active metabolite of nabumetone in human plasma and its application to bioequivalence study.
    Patel BN; Sharma N; Sanyal M; Prasad A; Shrivastav PS
    Biomed Chromatogr; 2008 Nov; 22(11):1213-24. PubMed ID: 18651608
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biocatalytic Characterization of Human FMO5: Unearthing Baeyer-Villiger Reactions in Humans.
    Fiorentini F; Geier M; Binda C; Winkler M; Faber K; Hall M; Mattevi A
    ACS Chem Biol; 2016 Apr; 11(4):1039-48. PubMed ID: 26771671
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extractionless determination of 6-methoxy-2-naphthylacetic acid, a major metabolite of nabumetone, in human plasma by high-performance liquid chromatography.
    de Jager AD; Hundt HK; Hundt AF; Swart KJ; Knight M; Roberts J
    J Chromatogr B Biomed Sci Appl; 2000 Apr; 740(2):247-51. PubMed ID: 10821411
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative biotransformation and disposition studies of nabumetone in humans and minipigs using high-performance liquid chromatography with ultraviolet, fluorescence and mass spectrometric detection.
    Nobilis M; Kopecký J; Kvetina J; Svoboda Z; Pour M; Kunes J; Holcapek M; Kolárová L
    J Pharm Biomed Anal; 2003 Aug; 32(4-5):641-56. PubMed ID: 12899954
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nabumetone: therapeutic use and safety profile in the management of osteoarthritis and rheumatoid arthritis.
    Hedner T; Samulesson O; Währborg P; Wadenvik H; Ung KA; Ekbom A
    Drugs; 2004; 64(20):2315-43; discussion 2344-5. PubMed ID: 15456329
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A pharmacokinetic study of the active metabolite of nabumetone in young healthy subjects and older arthritis patients.
    Kendall MJ; Chellingsworth MC; Jubb R; Thawley AR; Undre NA; Kill DC
    Eur J Clin Pharmacol; 1989; 36(3):299-305. PubMed ID: 2744071
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of enzymes responsible for the N-oxidation of darexaban glucuronide, the pharmacologically active metabolite of darexaban, and the glucuronidation of darexaban N-oxides in human liver microsomes.
    Shiraga T; Yajima K; Teragaki T; Suzuki K; Hashimoto T; Iwatsubo T; Miyashita A; Usui T
    Biol Pharm Bull; 2012; 35(3):413-21. PubMed ID: 22382330
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The participation of human hepatic P450 isoforms, flavin-containing monooxygenases and aldehyde oxidase in the biotransformation of the insecticide fenthion.
    Leoni C; Buratti FM; Testai E
    Toxicol Appl Pharmacol; 2008 Dec; 233(2):343-52. PubMed ID: 18845175
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Determination of 6-methoxy-2-naphthylacetic acid, a major metabolite of nabumetone, in human plasma by HPLC].
    Qin Y; Zou Y; Liang M; Huang Y; Yu Q
    Hua Xi Yi Ke Da Xue Xue Bao; 1999 Dec; 30(4):452-4. PubMed ID: 11387968
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of the antiinflammatory prodrug, nabumetone and its principal active metabolite on rat gastric mucosal, aortic and platelet eicosanoid synthesis, in vitro and ex vivo.
    Jeremy JY; Thompson CS; Mikhailidis DP; Dandona P
    Prostaglandins Leukot Essent Fatty Acids; 1990 Nov; 41(3):195-9. PubMed ID: 2281122
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nabumetone. Evidence for the lack of enterohepatic circulation of the active metabolite 6-MNA in humans.
    Brett MA; Buscher G; Ellrich E; Greb WH; Kurth HJ; Rülander G; Schmerenbeck B; Haddock RE; Thawley AR
    Drugs; 1990; 40 Suppl 5():67-70. PubMed ID: 2081498
    [No Abstract]   [Full Text] [Related]  

  • 32. Benzydamine N-oxidation as an index reaction reflecting FMO activity in human liver microsomes and impact of FMO3 polymorphisms on enzyme activity.
    Störmer E; Roots I; Brockmöller J
    Br J Clin Pharmacol; 2000 Dec; 50(6):553-61. PubMed ID: 11136294
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonsteroidal anti-inflammatory drug therapy and gastric side effects. Does nabumetone provide a solution?
    Dandona P; Jeremy JY
    Drugs; 1990; 40 Suppl 5():16-24. PubMed ID: 2081487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regioselective oxidation of phospho-NSAIDs by human cytochrome P450 and flavin monooxygenase isoforms: implications for their pharmacokinetic properties and safety.
    Xie G; Wong CC; Cheng KW; Huang L; Constantinides PP; Rigas B
    Br J Pharmacol; 2012 Sep; 167(1):222-32. PubMed ID: 22489789
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Species Differences in the Oxidative Desulfurization of a Thiouracil-Based Irreversible Myeloperoxidase Inactivator by Flavin-Containing Monooxygenase Enzymes.
    Eng H; Sharma R; Wolford A; Di L; Ruggeri RB; Buckbinder L; Conn EL; Dalvie DK; Kalgutkar AS
    Drug Metab Dispos; 2016 Aug; 44(8):1262-9. PubMed ID: 27079250
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced skin permeation of 6-methoxy-2-naphthylacetic acid by salt formation.
    Pawar V; Kumar HY; Giridhar R; Yadav MR
    Drug Deliv; 2015 May; 22(3):359-66. PubMed ID: 24670100
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Properties and features of nabumetone].
    Davies NM; McLachlan AJ
    Drugs; 2000; 59 Spec No 1():25-33. PubMed ID: 10841070
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liver insufficiency as a factor modifying the pharmacokinetic characteristic of the preparation nabumetone.
    Maleev A; Vlahov V; Gruev I; Dierdorf D; Kostova N; Bacracheva N
    Int J Clin Pharmacol Ther Toxicol; 1986 Aug; 24(8):425-9. PubMed ID: 3759278
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The in vitro effects of 6-methoxy-2-naphthylacetic acid, the active metabolite of nabumetone, on rat gastric mucosal eicosanoid synthesis and metabolism.
    Melarange R; Spangler R; Hoult JR
    Prostaglandins Leukot Essent Fatty Acids; 1996 Sep; 55(3):195-200. PubMed ID: 8931119
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disposition and excretion of 6-methoxy-2-naphthylacetic acid, the active metabolite of nabumetone in horses.
    Soma LR; Uboh CE; Rudy JA; Smith MS
    Am J Vet Res; 1996 Apr; 57(4):517-21. PubMed ID: 8712517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.